WCN26-4742 Multiple anti-slit autoantibodies in post-transplant recurrent focal segmental glomerulosclerosis

Read full text Summarise with VIRAT
Authors: Yoko Shirai, Kenichiro Miura, Naoko Ito, Sekiko Taneda, Junki Koike, Kazuho Honda, Motoshi Hattori
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We previously reported that anti-nephrin autoantibodies may act as a circulating factor responsible for post-transplant recurrent focal segmental glomerulosclerosis (rFSGS) (Hattori M, et al., Am J Transplant, 2022; Shirai Y, et al., Kidney Int, 2024). Recently, autoantibodies targeting slit diaphragm molecules other than nephrin have been described (Raglianti V, et al. Kidney Int, 2024; Shirai Y, et al., Kidney Int, 2025).

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Systemic Lupus Erythematosus Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105608–105608
Publication date
25 March 2026
Language
EN